Dynamic characteristics of net anthropogenic phosphorus input to the upper Yangtze River Basin from 1989 to 2019: Focus on the phosphate ore rich area in China.

Phosphorus (P), a non-renewable essential resource, faces heavy exploitation and contributes to eutrophication in aquatic environments. Assessing P input is vital for a healthier P cycle in the Upper Yangtze River (UYR), a phosphate ore rich basin, where P mining and P chemical enterprises have prominent pollution problems. This study modified the net anthropogenic phosphorus input (NAPI) model to include ore mining P input (Pore). We analyzed the evolutionary characteristics of P input in five sub-basins of UYR from 1989 to 2019 using prefecture-level data, and assessed the uncertainty of the data. NAPI in all sub-basins exhibited an upward and then downward trend during 1989-2019, with the inflection point occurring in 2015 or 2016, showing a net increase of about 1.1 times (568-1162 kg P km-2 yr-1) in the whole UYR basin. Among the components of NAPI, P fertilizer inputs (Pfer) and food/non-food and feed P inputs (Pf/nf&feed) contributed comparably, though the growth rate of Pfer was most notable basin-wide. Pore proportion increased significantly (about 3-fold), with a peak of 20%, especially in Wujiang sub-basin. The multi-year (1989-2019) average NAPI in UYR rose sequentially from west to east, with hotspot areas mainly concentrated in the Sichuan-Chongqing urban agglomeration and cities of Hubei province. The regional P input closely related to the population density and the level of agricultural development, certainly the phosphate mining was also unignorable. This study emphasizes that based on current status of NAPI development in UYR, targeted management for different regions should focus on improving agricultural P use efficiency and rational exploitation of P mineral resources.

The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.

BACKGROUND: Reduced bone mineral density (BMD) and osteoporosis are common in chronic liver diseases. However, the causal effect of alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) on BMD remains uncertain. OBJECTIVES: This study uses a two-sample Mendelian randomization (MR) design to evaluate the genetically predicted effect of ALD and NAFLD on BMDs using summary data from publically available genome-wide association studies (GWASs). METHODS: The GWAS summary statistics of ALD (1416 cases and 213,592 controls) and NAFLD (894 cases and 217,898 controls) were obtained from the FinnGen consortium. BMDs of four sites (total body, n = 56,284; femoral neck, n = 32,735; lumbar spine, n = 28,498; forearm, n = 8143) were from the GEnetic Factors for OSteoporosis Consortium. Data for alcohol consumption (n = 112,117) and smoking (n = 33,299) and serum 25-Hydroxyvitamin D (25-OHD) level (n = 417,580) were from UK-biobank. We first performed univariate MR analysis with the Inverse Variance Weighted (IVW) method as the primary analysis to investigate the genetically predicted effect of ALD or NAFLD on BMD. Then, multivariate MR and mediation analysis were performed to identify whether the effect was mediated by alcohol consumption, smoking, or serum 25-OHD level. RESULTS: The MR results suggested a robust genetically predicted effect of ALD on reduced BMD in the femoral neck (FN-BMD) (IVW beta = -0.0288; 95% CI: -0.0488, -0.00871; P = 0.00494) but not the other three sites. Serum 25-OHD level exhibited a significant mediating effect on the association between ALD and reduced FN-BMD albeit the proportion of mediation was mild (2.21%). No significant effects of NAFLD, alcohol consumption, or smoking on BMD in four sites, or reverse effect of BMD on ALD or NAFLD were detected. CONCLUSION: Our findings confirm the genetically predicted effect of ALD on reduced FN-BMD, and highlight the importance of periodic BMD and serum 25-OHD monitoring and vitamin D supplementation as needed in patients with ALD. Future research is required to validate our results and investigate the probable underlying mechanisms.

Phosphate removal and recovery by lanthanum-based adsorbents: A review for current advances.

Controlling eutrophication and recovering phosphate from water bodies are hot issues in the 21st century. Adsorption is considered to be the best method for phosphate removal because of its high adsorption efficiency and fast removal rate. Among the many adsorbents, lanthanum (La)-based adsorbents have been paid more and more attention due to their strong affinity to phosphorus. This paper reviews research of phosphate adsorption on La-based adsorbents in different La forms, including lanthanum oxide/hydroxide, lanthanum mixed metal oxide/hydroxide, lanthanum carbonate, La3+, La-based metal-organic framework (La-MOF) and La-MOF derivatives. The La-based adsorbents can be loaded on many carriers, such as carbon material, clay minerals, porous silica, polymers, industrial wastes, and others. We find that lanthanum oxide/hydroxide and La3+ adsorbents are mostly studied, while those in the forms of lanthanum carbonate, La-MOF, and La-MOF derivatives are relatively few. The kinetic process of most phosphate adsorption is pseudo-second-order and the isotherm process is in accordance with the Langmuir model. The cost of La-based and other traditional adsorbents was compared. The adsorption mechanisms are categorized as electrostatic attraction, ligand exchange, Lewis acid-base interaction, ion exchange and surface precipitation. Besides, regeneration methods of La-based adsorbents are mainly acid, alkali, and salt-alkali. In addition, the La-based adsorbents after absorbing phosphate can be directly used as a slow-release fertilizer. This review provides a basis for the research on phosphate adsorption by La-based adsorbents. It should be carried out to further develop La-based materials with high adsorption capacity and good regeneration ability. Meanwhile, studies have been conducted on the reuse of phosphate after desorption, which needs more attention in future research.

TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.

Objective: TNF-α-induced protein 3 ( TNFAIP3 ) is one of the major SLE susceptibility genes involved in the regulation of inflammatory responses through modulation of the nuclear factor-κB (NF-κB) pathway. We aim to assess TNFAIP3 expression in CD4 + T cells and the molecular mechanism underlying TNFAIP3 regulation in the pathogenesis of SLE. Methods: The expression and epigenetic regulation of TNFAIP3 in CD4 + T cells from SLE patients and normal controls (NCs) were investigated by RT-quantitative PCR, western blot and chromatin immunoprecipitation. The functional effect of TNFAIP3 was further evaluated by knockdown or overproduction of TNFAIP3 in CD4 + T cells from SLE patients and NCs. Results: TNFAIP3 mRNA was significantly downregulated in the CD4 + T cells of SLE patients compared with NCs. The reduced expression of TNFAIP3 was associated with the reduction of H3K4me3 in the gene promoter region. Functional blockage of TNFAIP3 in normal CD4 + T cells using small interfering RNA increased the expression of IFN-γ and IL-17, but not IL-2, IL-4 and IL-5. Nevertheless, overexpression of TNFAIP3 in CD4 + T cells from SLE patients resulted in the suppression of IFN-γ and IL-17 production. Conclusion: The downregulation of TNFAIP3 in CD4 + T cells of SLE was potentially regulated by demethylation of histone H3K4, which led to a decreased amount of H3K4me3 in the promoter of the TNFAIP3 gene. The dysregulation of TNFAIP3 in CD4 + T cells may contribute to the pathogenesis of SLE by overproduction of inflammatory cytokine IFN-γ and IL-17. TNFAIP3 may serve as a promising target for the treatment of SLE in clinical practice.

Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence.

Multicentric reticulohistiocytosis (MRH) is a rare and debilitating systemic disorder characterized by cutaneous nodules and destructive polyarthritis. Due to its unknown etiology, the treatment of MRH varies with different rates of success, which causes treatment options to be rather independent and empirical. In the present study, a case of a 48­year­old woman with a 12­month history of polyarthralgia and skin nodules was reported. Biopsy samples, which were obtained from her skin eruption exhibited dermal infiltration with histiocytes and multinucleated giant cells. Immunohistochemical staining indicated positivity for CD68. The patient was diagnosed with MRH and treated with a combination therapy of infliximab, prednisolone and methotrexate. Her symptoms improved markedly within 2 weeks. Following the results of this case study, a systematic review of 17 cases of MRH treated with tumor necrosis factor (TNF) antagonists was performed, and the efficacy of anti­TNF treatment in MRH was analyzed.

[The meaning of "nue" and "gu" in the Five Classical Canons and Huangdi Neijing (Yellow Emperor's Inner Canon)].

There were many terms of traditional Chinese medicine (TCM) in the Confucian Five Classical Canons, such as nue and gu. Among them, nue had the meaning of "sudden disease" or "cold disease" in the Spring and Autumn Period, which were changed to a name of disease, nue disease in the Warring States Period. In the Huangdi Neijing (Yellow Emperor's Inner Canon), there was a special treatise to discuss it. The original meaning of gu was poisonous insect, and then was explicated to a insect causing harm to people. Therefore, gu had the meaning of gathering gu for harming people, gu disease, gu poison and bug in the abdomen. Gu was recorded as a divinatory symbols in the Zhou Yi (The Book of Change), explained as a disease of heart-spirit confusion by later generations. Also, it was recorded in the Zuo Zhuan (The Commentary of Zuo Qiuming) and Huangdi Neijing.